Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure – Circulation - 2002
Brief Summary:
Carvedilol reduces risk of death or HF hospitalization by 31% compared to placebo in class III-IV HF with EF <25%.Reference: http://www.ncbi.nlm.nih.gov/pubmed/12390947
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you